| Charles W Yee, MD | |
|
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
| (810) 606-5530 | |
| Not Available |
| Full Name | Charles W Yee |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578521431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 81190 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles W Yee, MD 8775 Lakeview Blvd, Clarkston, MI 48348-3421 Ph: (810) 606-5530 | Charles W Yee, MD 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (810) 606-5530 |
News Archive
Robots are fluent in their native language of 1 and 0 absolutes but struggle to grasp the nuances and imprecise nature of human language.
Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.
A report in the 5th 2011 issue of Psychotherapy and Psychosomatics suggests the potential role of omega-3 fatty acid in preventing the psychological consequences of an accident.
A recent study reported by Haigang Chang and co-workers from the First Affiliated Hospital of Xinxiang Medical University in China verified the effects of transient axonal glycoprotein-1 (TAG-1) on cell viability and p53, epidermal growth factor receptor (EGFR), and amyloid precursor protein (APP) intracellular C-terminal domain (AICD) expression in U251 glioma cells.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
› Verified 7 days ago
Doina David, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Dr. Khushi Sweety Lokesh Nagori, MBBS Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 | |
Baraa Alosh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-7741 | |
Alan F Henke, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5560 | |
Moutaz Haiba, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 Fax: 810-733-8898 | |
Majd Jundi, MD Pathology Medicare: Medicare Enrolled Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 | |
Dr. Daniel Joseph Cowden, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9460 S Saginaw Rd Ste D, Grand Blanc, MI 48439 Phone: 810-733-7741 |